Medicine
Citric acid, Dextrose and Sodium citrate, unspecified form 0.4 g/1.225 g/1.1 g per 50 mL injection
Citric acid, Dextrose and Sodium citrate, unspecified form 0.4 g/1.225 g/1.1 g per 50 mL injection is a generic prescription medicine for extracorporeal use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Recommended storage Room temperature (68° to 77°F, 20°…
Key facts
- Active ingredient (INN)
- Citric acid, Dextrose and Sodium citrate, unspecified form
- Brand
- Sold under the generic name
- Strength
- 0.4 g/1.225 g/1.1 g per 50 mL
- Dosage form
- Injection
- Route
- Extracorporeal
- Packs
- 50 pouches of 50 mL
- Manufacturer
- Arteriocyte Medical Systems
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Recommended storage Room temperature (68° to 77°F, 20° to 25°C) Avoid excessive heat.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 May 2011
- Identifiers
- DailyMed set ID b850deac-161f-4bb0-ac7f-bceac2a230c0NDC 43203-852Application BA110057
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 pouch in 1 case / 1 bag in 1 pouch / 50 mL in 1 bag | 43203-852-47 | Arteriocyte Medical Systems | 11 May 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Citric acid, Dextrose and Sodium citrate, unspecified form 0.4 g/1.225 g/1.1 g per 50 mL injection.
Other strengths and forms of Citric acid, Dextrose and Sodium citrate, unspecified form
Clinical summary
Citric acid, Dextrose and Sodium citrate, unspecified form is a fixed-dose combination of an anti-coagulant, a calculi dissolution agent and an osmotic laxative. MedsAcross supplies Citric acid, Dextrose and Sodium citrate, unspecified form for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Citric acid, Dextrose and Sodium citrate, unspecified formFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Anticoagulant Citrate Dextrose (ACD-A) prescribing information (Terumo BCT) · U.S. National Library of Medicine, DailyMed
Need Citric acid, Dextrose and Sodium citrate, unspecified form 0.4 g/1.225 g/1.1 g per 50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.